Humana · Off Label NCCN · US health-plan appeal rights

Off Label NCCN denied as not FDA-approved for this use by Humana?

Q: How long do I have to appeal a Humana Off Label NCCN denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-11

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Humana typically requires

Humana's specific coverage criteria for off label nccn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Humana Oncology Pharmacy Prior Authorization Criteria (Medicare Advantage tied to CMS NCDs/LCDs)

The Humana angle on Off Label NCCN

## Why Humana Denied This NCCN-Supported Drug as Not FDA-Approved for Your Indication

This denial reflects a specific clinical reality: the drug has FDA approval for one or more indications, but your prescriber is requesting it for an indication that is not in the FDA-approved labeling. Humana's automated review flagged the off-label use. This is not a denial that the drug is unapproved in general — it is a denial that your specific indication falls outside the approved label. Off-label use is a legal and common medical practice, and coverage of off-label oncology drugs supported by the NCCN Compendium is specifically addressed in most major insurance frameworks.

## Why This Is Appealable

Federal law and the law of most states distinguish between FDA-approved use and medically accepted use. Compendia such as the NCCN Compendium exist precisely to provide evidence-based guidance for off-label indications. Humana's own coverage policies typically reference NCCN as an accepted standard; a blanket not-FDA-approved denial that ignores an applicable NCCN listing is an incomplete clinical review that can be challenged.

## Federal Appeal Framework

Internal appeal: File within the timeframe on your EOB. Request Humana's off-label use policy and the specific compendia they recognize. Explicitly cite the NCCN listing in your appeal.
External review (ACA §2719): If the internal appeal is denied, an independent IRO will review whether the off-label use meets recognized standards of care. Standard window is approximately four months; expedited review is available for urgent situations.
ERISA §503 (employer plans): You are entitled to all documents used in the review, including which compendia were consulted.

## Documentation to Gather

1. Diagnosis and indication specifics — pathology, genetic/molecular markers, staging that identify exactly which off-label indication applies. 2. NCCN compendium printout — the specific NCCN category listing for this drug and your exact indication, downloaded from NCCN.org. 3. Published literature summary — your oncologist's summary of the key evidence base supporting this off-label use. 4. Prescriber medical-necessity letter — explaining why this off-label use is medically necessary and consistent with recognized standards. 5. Humana's off-label policy — request their published policy on compendium-supported off-label use to cite in your appeal.

## Criteria-Mapping Structure

Identify each criterion in Humana's off-label coverage policy. Map each to a specific piece of evidence: the NCCN listing category, the prescriber's rationale, and the clinical records. Submit as a structured point-by-point rebuttal, with each exhibit clearly labeled.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Humana appeals

Other insurers on Off Label NCCN

Aetna denied as not FDA-approved for this use of Off Label NCCN

Other denial reasons for Humana Off Label NCCN

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-11. Editorial standards: denialhelp.com/authors.